Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Yuchen Zhang, Rafael Andrade, Anthony A. Hanna & Mary Kay H. Pflum. (2022) Evidence that HDAC7 acts as an epigenetic “reader” of AR acetylation through NCoR-HDAC3 dissociation. Cell Chemical Biology 29:7, pages 1162-1173.e5.
Crossref
Crossref
Liqian Ma, Wonhwa Cho & Erik R. Nelson. (2022) Our evolving understanding of how 27-hydroxycholesterol influences cancer. Biochemical Pharmacology 196, pages 114621.
Crossref
Crossref
Ho Tsoi, Ling Shi, Man-Hong Leung, Ellen P. S. Man, Zi-Qing So, Wing-Lok Chan & Ui-Soon Khoo. (2022) Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 12:1, pages 93.
Crossref
Crossref
Faiz-ul Hassan, Asif Nadeem, Zhipeng Li, Maryam Javed, Qingyou Liu, Jahanzaib Azhar, Muhammad Saif-ur Rehman, Kuiqing Cui & Saif ur Rehman. (2021) Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions. International Journal of Molecular Sciences 22:22, pages 12463.
Crossref
Crossref
Demelza M. Smeeth, Ioanna Kourouzidou, Rodrigo R.R. Duarte, Timothy R. Powell & Sandrine Thuret. (2021) Prolactin, Estradiol and Testosterone Differentially Impact Human Hippocampal Neurogenesis in an In Vitro Model. Neuroscience 454, pages 15-39.
Crossref
Crossref
Tingting Ma, Yiran Liang, Yaming Li, Xiaojin Song, Ning Zhang, Xiaoyan Li, Bing Chen, Wenjing Zhao, Lijuan Wang & Qifeng Yang. (2020) LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer. Cellular Signalling 68, pages 109536.
Crossref
Crossref
Céline Basset, Florence Bonnet-Magnaval, Marina Garcia-Jove Navarro, Christian Touriol, Monique Courtade, Hervé Prats, Barbara Garmy-Susini & Eric Lacazette. (2017) Api5 a new cofactor of estrogen receptor alpha involved in breast cancer outcome. Oncotarget 8:32, pages 52511-52526.
Crossref
Crossref
Minna Saaristo, Bob B.M. Wong, Laura Mincarelli, Allison Craig, Christopher P. Johnstone, Mayumi Allinson, Kai Lindström & John A. Craft. (2017) Characterisation of the transcriptome of male and female wild-type guppy brains with RNA-Seq and consequences of exposure to the pharmaceutical pollutant, 17α-ethinyl estradiol. Aquatic Toxicology 186, pages 28-39.
Crossref
Crossref
Juliana Fattori, Jéssica L. O. Campos, Tábata R. Doratioto, Lucas M. Assis, Mariela T. Vitorino, Igor Polikarpov, José Xavier-Neto & Ana Carolina M. Figueira. (2015) RXR Agonist Modulates TR: Corepressor Dissociation Upon 9-cis Retinoic Acid Treatment. Molecular Endocrinology 29:2, pages 258-273.
Crossref
Crossref
Weiliang Sun, Chijiang Gu, Minming Xia, Guoping Zhong, Haojun Song & Junming Guo. (2014) Significance of estrogen receptor subtypes in breast tumorigenesis and progression. Tumor Biology 35:9, pages 9111-9117.
Crossref
Crossref
Sandipan Chakraborty & Pradip Kumar Biswas. (2014) Structural insights into selective agonist actions of tamoxifen on human estrogen receptor alpha. Journal of Molecular Modeling 20:8.
Crossref
Crossref
Samaan Samaan, Léon-Charles Tranchevent, Etienne Dardenne, Micaela Polay Espinoza, Eleonora Zonta, Sophie Germann, Lise Gratadou, Martin Dutertre & Didier Auboeuf. (2014) The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways. Nucleic Acids Research 42:4, pages 2197-2207.
Crossref
Crossref
Mei Ji, Yuhuan Liu, Shengsheng Yang, Dongxia Zhai, Danying Zhang, Lingling Bai, Zhenzhi Wang, Jin Yu, Chaoqin Yu & Zailong Cai. (2013) Puerarin suppresses proliferation of endometriotic stromal cells in part via differential recruitment of nuclear receptor coregulators to estrogen receptor-α. The Journal of Steroid Biochemistry and Molecular Biology 138, pages 421-426.
Crossref
Crossref
Tetsuro Yoshimaru, Masato Komatsu, Taisuke Matsuo, Yi-An Chen, Yoichi Murakami, Kenji Mizuguchi, Eiichi Mizohata, Tsuyoshi Inoue, Miki Akiyama, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Yasuo Miyoshi, Mitsunori Sasa, Yusuke Nakamura & Toyomasa Katagiri. (2013) Targeting BIG3–PHB2 interaction to overcome tamoxifen resistance in breast cancer cells. Nature Communications 4:1.
Crossref
Crossref
Luduo Zhang, Chun Gong, Samantha L.Y. Lau, Nan Yang, Oscar G.W. Wong, Annie N.Y. Cheung, Janice W.H. Tsang, Kelvin Y.K. Chan & Ui-Soon Khoo. (2013)
SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of
NCOR2/SMRT
That Is Associated with Tamoxifen Resistance and Control of
ERα
Transcriptional Activity
. Cancer Research 73:1, pages 246-255.
Crossref
Crossref
V. Bartella, P. Rizza, I. Barone, D. Zito, F. Giordano, C. Giordano, S. Catalano, L. Mauro, D. Sisci, M. L. Panno, S. A. W. Fuqua & S. Andò. (2012) Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter. Breast Cancer Research and Treatment 134:2, pages 569-581.
Crossref
Crossref
Brenda J. Mengeling, Michael L. Goodson, William Bourguet & Martin L. Privalsky. (2012) SMRTε, a corepressor variant, interacts with a restricted subset of nuclear receptors, including the retinoic acid receptors α and β. Molecular and Cellular Endocrinology 351:2, pages 306-316.
Crossref
Crossref
Jun Yang & Peter J. Fuller. (2012) Interactions of the mineralocorticoid receptor – Within and without. Molecular and Cellular Endocrinology 350:2, pages 196-205.
Crossref
Crossref
Zhengtang Qi & Shuzhe Ding. (2012)
Transcriptional Regulation by Nuclear Corepressors and PGC-1
α
: Implications for Mitochondrial Quality Control and Insulin Sensitivity
. PPAR Research 2012, pages 1-12.
Crossref
Crossref
Jing Zhong, Ren-Xian Cao, Xu-Yu Zu, Tao Hong, Jing Yang, Ling Liu, Xin-Hua Xiao, Wen-Jun Ding, Qiang Zhao, Jiang-Hua Liu & Ge-Bo Wen. (2012) Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma. FEBS Journal 279:2, pages 316-335.
Crossref
Crossref
Peter J. Watson, Louise Fairall & John W.R. Schwabe. (2012) Nuclear hormone receptor co-repressors: Structure and function. Molecular and Cellular Endocrinology 348:2, pages 440-449.
Crossref
Crossref
Michael J. Bolt, Sean M. Hartig, Adam T. Szafran, Sanjay N. Mediwala, Marco Marcelli & Michael A. Mancini. 2012. Advances in Rapid Sex-Steroid Action. Advances in Rapid Sex-Steroid Action
227
252
.
Michael L. Goodson, Brenda J. Mengeling, Brian A. Jonas & Martin L. Privalsky. (2011) Alternative mRNA Splicing of Corepressors Generates Variants That Play Opposing Roles in Adipocyte Differentiation. Journal of Biological Chemistry 286:52, pages 44988-44999.
Crossref
Crossref
Grant Buchanan, Eleanor F. Need, Jeffrey M. Barrett, Tina Bianco-Miotto, Vanessa C. Thompson, Lisa M. Butler, Villis R. Marshall, Wayne D. Tilley & Gerhard A. Coetzee. (2011) Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Molecular and Cellular Endocrinology 342:1-2, pages 20-31.
Crossref
Crossref
Francesc X. SorianoFrédéric LéveilléSofia PapadiaKaren F.S. BellClare PuddifootGiles E. Hardingham. (2011) Neuronal Activity Controls the Antagonistic Balance Between Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α and Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptors in Regulating Antioxidant Defenses. Antioxidants & Redox Signaling 14:8, pages 1425-1436.
Crossref
Crossref
Benito Campos, Justo Lorenzo Bermejo, Lin Han, Jörg Felsberg, Rezvan Ahmadi, Niels Grabe, Guido Reifenberger, Andreas Unterberg & Christel Herold-Mende. (2011) Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas. Cancer Science 102:2, pages 387-392.
Crossref
Crossref
Elaine Y. Hsia, Michael L. Goodson, June X. Zou, Martin L. Privalsky & Hong-Wu Chen. (2010) Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Advanced Drug Delivery Reviews 62:13, pages 1227-1237.
Crossref
Crossref